【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Cardiac Pacemakers Overview 8
3 Products under Development 9
3.1 Cardiac Pacemakers – Pipeline Products by Stage of Development 9
3.2 Cardiac Pacemakers – Pipeline Products by Segment 10
3.3 Cardiac Pacemakers – Pipeline Products by Territory 11
3.4 Cardiac Pacemakers – Pipeline Products by Regulatory Path 12
3.5 Cardiac Pacemakers – Pipeline Products by Estimated Approval Date 13
3.6 Cardiac Pacemakers – Ongoing Clinical Trials 14
4 Cardiac Pacemakers – Pipeline Products under Development by Companies 15
4.1 Cardiac Pacemakers Companies – Pipeline Products by Stage of Development 15
4.2 Cardiac Pacemakers – Pipeline Products by Stage of Development 16
5 Cardiac Pacemakers Companies and Product Overview 17
5.1 Boston Scientific Corporation Company Overview 17
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Boston TransTec, LLC Company Overview 21
5.2.1 Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Duke University Company Overview 22
5.3.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 EBR Systems, Inc. Company Overview 23
5.4.1 EBR Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Hadasit Medical Research Services & Development Ltd Company Overview 27
5.5.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 InnerPulse, Inc. Company Overview 29
5.6.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Kenergy Inc. Company Overview 30
5.7.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Krisara Engineering, LLC Company Overview 31
5.8.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 LivaNova PLC Company Overview 32
5.9.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.10 Mathematical Bio-Solutions Inc. Company Overview 39
5.10.1 Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.11 Mayo Clinic US Company Overview 40
5.11.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Medtronic plc Company Overview 41
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 41
5.13 MicroPort Scientific Corporation Company Overview 47
5.13.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.14 NDSU Research Foundation Company Overview 48
5.14.1 NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 48
5.15 NuVascular Technologies Inc Company Overview 49
5.15.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.16 Perpetuum Ltd. Company Overview 50
5.16.1 Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 St. Jude Medical, Inc. Company Overview 51
5.17.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.18 University of Bern Company Overview 57
5.18.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 57
5.19 University of California, Los Angeles Company Overview 58
5.19.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 58
5.20 University of Michigan Company Overview 59
5.20.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 59
6 Cardiac Pacemakers – Recent Developments 60
6.1 Jul 01, 2016: BIOTRONIK Pacemakers that Automatically Adapt to MRI Environments Get CE Approval 60
6.2 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 60
6.3 Jun 27, 2016: Greatbatch Renamed Integer Holdings 61
6.4 Jun 21, 2016: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center First in Texas to Use Micra Transcatheter Pacing System Post FDA Approval 61
6.5 Jun 09, 2016: New Data Further Demonstrate Safety Benefits for World’s Smallest Pacemaker 62
6.6 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 63
6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 64
6.8 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 64
6.9 May 26, 2016: Northwestern Medicine Cardiologist First in Illinois to Implant World’s Smallest FDA-Approved Pacemaker 67
6.10 May 10, 2016: AVX releases MQ Series medical grade MLCCs 67
6.11 May 06, 2016: New Data Showcases the Long-Term Clinical Benefits of the Nanostim Leadless Pacemaker Compared to Traditional Pacemakers 68
6.12 May 05, 2016: New Data Further Support Medtronic Leadership in Leadless Pacing at Heart Rhythm 2016 69
6.13 May 05, 2016: St. Jude Medical Announces MultiPoint Pacing IDE Study Results During Late-Breaker at Heart Rhythm 2016 70
6.14 May 05, 2016: The Parkview Mirro Center for Research and Innovation Initiates Study to Demonstrate Value of Personalized Patient Engagement for Those Suffering from Heart Failure 71
6.15 May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 72
6.16 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 73
6.17 Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion 75
6.18 Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results 76
6.19 Apr 18, 2016: Material in Medtronic Leads Inducted into Space Technology Hall of Fame 77
6.20 Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment 78
6.21 Apr 06, 2016: FDA approves first leadless pacemaker to treat heart rhythm disorders 78
6.22 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury’s Recent Temporary and Proposed Regulations 79
6.23 Mar 17, 2016: Medtronic Proposes Proxy Access 79
6.24 Mar 10, 2016: St. Jude Medical Secures CE Mark Approval of MRI Compatibility for the Nanostim Leadless Pacemaker 80
6.25 Mar 08, 2016: EBR Systems Announces First Commercial Implants of WiSE Technology 81
6.26 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 82
6.27 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 83
6.28 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 86
6.29 Feb 18, 2016: FDA Panel Provides Leadership and Guidance to Companies Seeking to Advance Leadless Pacing Technology in the U.S. 86
6.30 Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification 87
6.31 Jan 29, 2016: Medtronic To Present Data On Micra Transcatheter Pacing System At Upcoming FDA Advisory Committee Meeting 87
6.32 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 88
6.33 Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results 88
6.34 Jan 26, 2016: Greatbatch Awarded $37.5 Million in Patent Infringement Lawsuit Against AVX 91
6.35 Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results 91
6.36 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 92
6.37 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 93
6.38 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 93
6.39 Dec 01, 2015: World’s Only Company to Offer Japan’s ICD and Pacemaker Patients 3 Tesla MRI Access 94
6.40 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 95
6.41 Nov 18, 2015: Latest Cardiac Advancements from Medtronic Win 2015 ‘Best of What’s New’ Awards from Popular Science 95
6.42 Nov 09, 2015: World’s Smallest Pacemaker, Medtronic Micra TPS, Meets Global Clinical Trial’s Safety and Effectiveness Endpoints 95
6.43 Nov 09, 2015: BIOTRONIK Affirms Commitment to Physician Education at Forum Featuring World Leading Electrophysiologists 97
6.44 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 97
6.45 Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results 100
6.46 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 101
6.47 Oct 05, 2015: EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure 102
6.48 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 103
6.49 Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team 103
6.50 Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova’s Chief Financial Officer 104
6.51 Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan 104
6.52 Sep 08, 2015: No Further Legal Action By Italian State’s Attorney To Enjoin The Combination Of Sorin And Cyberonics 106
6.53 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 106
6.54 Aug 30, 2015: St. Jude Medical Presents Nanostim’s Primary Results From Leadless II Study 109
6.55 Aug 26, 2015: Greatbatch Partners with Wireless Power Leader WiTricity to Provide Wireless Charging for Medical Devices 109
6.56 Aug 07, 2015: Financial Results for the First Quarter of Fiscal Year Ending March 31, 2016 110
6.57 Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors 112
6.58 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 112
6.59 Jul 30, 2015: Greatbatch Reports 2015 Second Quarter Results 113
6.60 Jul 30, 2015: Sorin Group Announces Results for the Second Quarter of 2015 116
6.61 Jul 27, 2015: Sorin And Cyberonics Announce Intent To Vigorously Contest Claim By Italian State’s Attorney Seeking To Enjoin The Proposed Combination Of The Companies 118
6.62 Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results 119
6.63 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 120
7 Appendix 122
7.1 Methodology 122
7.2 About GlobalData 124
7.3 Contact Us 125
7.4 Disclaimer 125
【レポート販売概要】
■ タイトル：世界の心臓ペースメーカー市場：医療機器パイプライン分析2016■ 英文：Cardiac Pacemakers - Medical Devices Pipeline Assessment, 2016
■ 発行日：2016年7月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0210EPD
■ 調査対象地域：グローバル
- グローバルにおける農業・林業用トラクター市場（～2019）The industry report Global Agricultural and Forestry Tractor Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for agricultural and forestry tractors in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for ind …
- 反射材料の世界市場分析：製品別（生地、シート、塗料、インクの製造、テープおよびフィルム、コーティング、専門商品）、用途別（テキスタイル、建設・道路、自動車、電子･半導体）、セグメント予測、2014-2025The global reflective materials market value is anticipated to reach USD 31.14 billion by 2025, according to a new report by Grand View Research, Inc. The rising high-visibility fabric demand for the work place and safety and traffic management is expected to be a key factor steering the growth in the coming years. Applications predominately include coatings use in the construction & roads and tex …
- クラウドCDN（コンテンツデリバリネットワーク）の世界市場予測（～2021）MarketsandMarkets forecasts the Cloud Content Delivery Network market size to grow from USD 1.81 Billion in 2016 to USD 6.23 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 28.0%. Major factors contributing to the growth of the cloud CDN market are growing rich media file contents, video content, increasing use of connected and smart devices, and proliferation of rich media …
- ポンプの世界市場：渦巻ポンプ、特殊ポンプ、容積式ポンプAbout the Pump Market Although overall global growth in the global pump market is likely to be robust, the factors that will fuel this growth will vary from region to region. In emerging economies such as India and China, the growth will primarily be the result of rapid industrialization as investment in the power generation and water infrastructure sectors grows. In the developed countries, impro …
- 鉱物綿の世界市場：ガラス綿、ロックウール（岩綿）The mineral wool market can be segmented into four major regions, which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). Ceramic fiber finds usage in different types of insulation applications such as Fire protection, Thermal insulation, Acoustic insulations, and other applications. The mineral wool market is a growing market, the mineral wool market in the Asia-Pacific region …
- Technological Know-How of Leading Life Science Intermediates Companies 2014This new report from Venture Planning Group provides technological know-how of leading life science intermediates companies. The report presents: Internally developed and acquired technologies, and related capabilities.Proprietary technologies and patent litigations.The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Con …
- コンプレッサ制御装置の世界市場ABSTRACTAbout Compressor Control Systems Compressor control systems are mainly used to control compressors and improve their efficiency. Hardware components used in compressors send signals and data to software applications, which help in controlling functionalities of compressors. Hardware components are extensively used as these act as the basic elements to support the functionalities of compres …
- Machine-to-Machine (M2M) and RFIDMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- 世界の高電圧開閉装置市場2015The Global High-voltage Switchgear Industry Report 2015 is a professional and in-depth study on the current state of the High-voltage Switchgear industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The High-voltage Switchgear market analysis is provided for the international markets including development tr …
- ウェアラブル医療機器の世界市場予測（～2021）：用途別（診断、治療）、需要先別、種類別（スマートウォッチ、パッチ）、流通チャネル別The global wearable medical devices market, in terms of value, is projected to reach USD 12.14 Billion by 2021 from USD 5.31 Billion in 2016, at a CAGR of 18.0% during the forecast period. Growth in this market is mainly driven by technological advancements in medical devices, launch of a growing number of smartphone-based healthcare apps compatible with wearable devices, rising preference for wir …
- 世界の医療用ガス市場Medical gases include gases used during surgical procedures, medical procedures, sterility purposes and other uses such as coolant. The market has a healthy CAGR and is expected to grow over $16 billion by 2021. The market is driven by various factors such as rise in the number of surgical procedures, number of hospitals, point of care health services and other macroeconomic factor such as health …
- 接着剤・シーラント剤の世界市場：技術別、製品別、アプリケーション別、地域別、セグメント予測The global adhesives and sealants market size is expected to reach USD 82.4 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.6% during the forecast period. High demand for adhesives and sealants from construction, packaging, assembly, and automotive sectors coupled with their rapidly expanding application scope are the significant f …
- 世界の急性リンパ性白血病/急性リンパ芽球性白血病治療市場The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential as the incidence rate of the disease is increasing all over the globe. The incidence of acute lymphocytic/lymphoblastic leukemia is higher in children from 0 to 14 years than in those aged 15 years and above. However, acute lymphocytic/lymphoblastic leukemia may also occur in adults. The acute lymphocytic/lymphob …
- 世界のデマンドレスポンス管理システム(DRMS)市場予測及び分析(2014-2019)Demand Response Management System (DRMS) is a proven software technology platform that enables market operators and utilities to manage and implement the Demand Response (DR) program through a single integrated management system. It helps in reducing the imbalance between energy supply and demand. Price-based and incentive-based are two types of demand response programs. DRMS solutions available i …
- 腫瘍用バイオ後続品の世界市場：がん治療薬、支持療法用薬About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components …
